Inventor · disambiguated record
Bitao Liang
Also filed as: LIANG BITAO
9 granted patents·10 pending applications·35 citations·filing 2011–2021
84Inventor score
Top patents by PatentIndex Score
19 records- 0190US10150816B2Chimeric antigen receptorsCELGENE CORP·Filed 2013·Granted Dec 11, 2018·15 cites·10 claims
- 0289US11130820B2Chimeric antigen receptorsCELGENE CORP·Filed 2018·Granted Sep 28, 2021·4 cites·12 claims
- 0387US8562973B2Treatment of sarcoidosis using placental stem cellsEDINGER JAMES W·Filed 2011·Granted Oct 22, 2013·12 cites·23 claims
- 0478US10238690B2Modified T lymphocytes comprising an inducible caspase and methods of apoptosisCELGENE CORP·Filed 2014·Granted Mar 26, 2019·3 cites·12 claims
- 0573US10982189B2Methods of improving vector transduction efficiency into T lymphocytesCELGENE CORP·Filed 2015·Granted Apr 20, 2021·1 cites·18 claims
- 0670US11806365B2Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of apoptosisCELGENE CORP·Filed 2021·Granted Nov 7, 2023·0 cites·20 claims
- 0770US11629335B2Methods of improving vector transduction efficiency into T lymphocytesCELGENE CORP·Filed 2021·Granted Apr 18, 2023·0 cites·22 claims
- 0870US10967005B2Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of apoptosisCELGENE CORP·Filed 2019·Granted Apr 6, 2021·0 cites·18 claims
- 0968US2022106404A1Chimeric antigen receptorsCELGENE CORP·Filed 2021·Application pending·0 cites
- 1060US2021254003A1Car-t lymphocytes engineered to home to lymph node b cell zone, skin, or gastrointestinal tractCELGENE CORP·Filed 2020·Application pending·0 cites
- 1151US2015368360A1Modified t lymphocytes having improved specificityANTHROGENESIS CORP·Filed 2014·Application pending·0 cites
- 1249US2014219970A1Treatment of sarcoidosis using placental stem cellsANTHROGENESIS CORP·Filed 2013·Application pending·0 cites
- 1349US2015118265A1Modified erythrocyte precursor cells and uses thereofANTHROGENESIS CORP·Filed 2013·Application pending·0 cites
- 1449US2018273640A1Modified t lymphocytes having improved specificityCELGENE CORP·Filed 2018·Application pending·0 cites
- 1547US2018080008A1Car-t lymphocytes engineered to home to lymph node b cell zone, skin, or gastrointestinal tractANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 1638US11834675B2T lymphocyte production methods and t lymphocytes produced therebyCELGENE CORP·Filed 2016·Granted Dec 5, 2023·0 cites·25 claims
- 1737US2012164114A1Treatment of immune-related diseases and disorders using amnion derived adherent cellsABBOT STEWART·Filed 2011·Application pending·0 cites
- 1836US2012156230A1Treatment of spinal cord injury and traumatic brain injury using placental stem cellsABBOT STEWART·Filed 2011·Application pending·0 cites
- 1936US2012201787A1Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cellsABBOT STEWART·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bitao Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →